PL106363B1 - Sposob wytwarzania 2-bromo-ergokryptyny - Google Patents
Sposob wytwarzania 2-bromo-ergokryptyny Download PDFInfo
- Publication number
- PL106363B1 PL106363B1 PL1977202697A PL20269777A PL106363B1 PL 106363 B1 PL106363 B1 PL 106363B1 PL 1977202697 A PL1977202697 A PL 1977202697A PL 20269777 A PL20269777 A PL 20269777A PL 106363 B1 PL106363 B1 PL 106363B1
- Authority
- PL
- Poland
- Prior art keywords
- bromo
- ergocryptine
- ergocriptine
- radical initiator
- ergocriptin
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 claims description 11
- YDOTUXAWKBPQJW-UHFFFAOYSA-N alpha-Ergocryptinine Natural products C1=CC(C=2C(N(C)CC(C=2)C(=O)NC2(C(=O)N3C(C(N4CCCC4C3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=CNC3=C1 YDOTUXAWKBPQJW-UHFFFAOYSA-N 0.000 claims description 9
- 229950001817 alpha-ergocryptine Drugs 0.000 claims description 7
- 239000003999 initiator Substances 0.000 claims description 6
- 238000005893 bromination reaction Methods 0.000 claims description 5
- 150000004292 cyclic ethers Chemical class 0.000 claims description 5
- YDOTUXAWKBPQJW-NSLWYYNWSA-N alpha-ergocryptine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=CNC3=C1 YDOTUXAWKBPQJW-NSLWYYNWSA-N 0.000 claims description 4
- 239000012298 atmosphere Substances 0.000 claims description 4
- 230000031709 bromination Effects 0.000 claims description 4
- 239000011261 inert gas Substances 0.000 claims description 4
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims description 3
- QRADPXNAURXMSB-UHFFFAOYSA-N 2-bromo-1,1-dioxo-1,2-benzothiazol-3-one Chemical compound C1=CC=C2S(=O)(=O)N(Br)C(=O)C2=C1 QRADPXNAURXMSB-UHFFFAOYSA-N 0.000 claims description 2
- OZVBMTJYIDMWIL-AYFBDAFISA-N bromocriptine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=C(Br)NC3=C1 OZVBMTJYIDMWIL-AYFBDAFISA-N 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 125000000532 dioxanyl group Chemical group 0.000 claims 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 150000003254 radicals Chemical class 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- 102100024819 Prolactin Human genes 0.000 description 2
- 108010057464 Prolactin Proteins 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- LRDFRRGEGBBSRN-UHFFFAOYSA-N isobutyronitrile Chemical compound CC(C)C#N LRDFRRGEGBBSRN-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229940097325 prolactin Drugs 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 1
- MARXMDRWROUXMD-UHFFFAOYSA-N 2-bromoisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(Br)C(=O)C2=C1 MARXMDRWROUXMD-UHFFFAOYSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 102000015554 Dopamine receptor Human genes 0.000 description 1
- 108050004812 Dopamine receptor Proteins 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- -1 N-bromocaprolacts Chemical compound 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 229940123796 Prolactin inhibitor Drugs 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 102100038803 Somatotropin Human genes 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229960003133 ergot alkaloid Drugs 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- QYZFTMMPKCOTAN-UHFFFAOYSA-N n-[2-(2-hydroxyethylamino)ethyl]-2-[[1-[2-(2-hydroxyethylamino)ethylamino]-2-methyl-1-oxopropan-2-yl]diazenyl]-2-methylpropanamide Chemical compound OCCNCCNC(=O)C(C)(C)N=NC(C)(C)C(=O)NCCNCCO QYZFTMMPKCOTAN-UHFFFAOYSA-N 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000005373 porous glass Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/02—Ergot alkaloids of the cyclic peptide type
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| YU3134/76A YU39786B (en) | 1976-12-23 | 1976-12-23 | Process for preparing 2-bromo-alfa-ergocriptine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL202697A1 PL202697A1 (pl) | 1978-07-31 |
| PL106363B1 true PL106363B1 (pl) | 1979-12-31 |
Family
ID=25559398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1977202697A PL106363B1 (pl) | 1976-12-23 | 1977-12-07 | Sposob wytwarzania 2-bromo-ergokryptyny |
Country Status (18)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| YU216177A (en) | 1977-09-09 | 1984-02-29 | Rudolf Rucman | Process for preparing 2-bromo ergosine |
| YU39849B (en) * | 1978-09-26 | 1985-04-30 | Lek Tovarna Farmacevtskih | Process for preparing 2-bromo-ergolene and 2-bromo-ergoline compounds |
| RU2274640C1 (ru) * | 2004-09-15 | 2006-04-20 | Всероссийский научно-исследовательский институт лекарственных и ароматических растений ("ВИЛАР") | СПОСОБ БРОМИРОВАНИЯ α И β-ЭРГОКРИПТИНОВ |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH507249A (de) * | 1968-05-31 | 1971-05-15 | Sandoz Ag | Verfahren zur Herstellung von 2-Brom-a-ergokryptin |
| YU216177A (en) * | 1977-09-09 | 1984-02-29 | Rudolf Rucman | Process for preparing 2-bromo ergosine |
-
1976
- 1976-12-23 YU YU3134/76A patent/YU39786B/xx unknown
-
1977
- 1977-11-24 DE DE2752532A patent/DE2752532C3/de not_active Expired
- 1977-11-29 PT PT67340A patent/PT67340A/pt unknown
- 1977-11-29 HU HU77LE820A patent/HU176817B/hu unknown
- 1977-12-02 CS CS778043A patent/CS215105B2/cs unknown
- 1977-12-05 JP JP14522377A patent/JPS5384997A/ja active Granted
- 1977-12-07 PL PL1977202697A patent/PL106363B1/pl unknown
- 1977-12-07 GB GB50918/77A patent/GB1574479A/en not_active Expired
- 1977-12-12 RO RO7792428A patent/RO71277A/ro unknown
- 1977-12-13 SU SU772553348A patent/SU795477A3/ru active
- 1977-12-13 UA UA2553348A patent/UA8031A1/uk unknown
- 1977-12-14 DD DD77202623A patent/DD134101A1/xx unknown
- 1977-12-15 ES ES465096A patent/ES465096A1/es not_active Expired
- 1977-12-23 FR FR7738976A patent/FR2375242A1/fr active Granted
-
1985
- 1985-09-20 BE BE1/011337A patent/BE903269Q/fr not_active IP Right Cessation
- 1985-10-02 SG SG718/85A patent/SG71885G/en unknown
- 1985-10-11 KE KE3572A patent/KE3572A/xx unknown
-
1986
- 1986-01-23 HK HK47/86A patent/HK4786A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KE3572A (en) | 1985-11-08 |
| RO71277A (ro) | 1982-02-01 |
| YU313476A (en) | 1982-05-31 |
| DD134101A1 (de) | 1979-02-07 |
| ES465096A1 (es) | 1978-09-01 |
| DE2752532C3 (de) | 1980-09-18 |
| FR2375242B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1983-01-14 |
| HU176817B (en) | 1981-05-28 |
| PL202697A1 (pl) | 1978-07-31 |
| JPS5550038B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1980-12-16 |
| PT67340A (en) | 1977-12-01 |
| YU39786B (en) | 1985-04-30 |
| JPS5384997A (en) | 1978-07-26 |
| FR2375242A1 (fr) | 1978-07-21 |
| DE2752532B2 (de) | 1979-12-06 |
| CS215105B2 (en) | 1982-07-30 |
| SU795477A3 (ru) | 1981-01-07 |
| DE2752532A1 (de) | 1978-06-29 |
| HK4786A (en) | 1986-01-31 |
| GB1574479A (en) | 1980-09-10 |
| BE903269Q (fr) | 1986-01-16 |
| SG71885G (en) | 1988-09-30 |
| UA8031A1 (uk) | 1995-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4348391A (en) | Sulfonamido and sulfamoylamino-ergoline-I derivatives | |
| DK144160B (da) | Analogifremgangsmaade til fremstilling af 8-thiomethylergoliner | |
| CA2915470A1 (en) | Antagonists of prostaglandin ep3 receptor | |
| Yates et al. | Festucine, an alkaloid from tall fescue (Festuca arundinacea Schreb.): chemistry of the functional groups | |
| Ayer et al. | The structure of lycodine | |
| PL106363B1 (pl) | Sposob wytwarzania 2-bromo-ergokryptyny | |
| FI61188C (fi) | Foerfarande foer framstaellning av 8alfa-syanometylergolin-i-foereningar med dopaminergisk och prolaktinsekretionshaemmande verkan | |
| US3654280A (en) | L-n allylic-3-hydroxy-6-oxomorphinans | |
| NO128533B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| CA1149801A (en) | Ergol-8-ene and ergolin compounds and process for preparing same | |
| SU843753A3 (ru) | Способ получени димерных индолдигидроиндолдионовых соединений | |
| DK146822B (da) | Analogifremgangsmaade til fremstilling af derivater af 4-desacetyl-vinblastin eller salte deraf | |
| US4772632A (en) | Antineoplastic, system - L specific amino acid nitrogen mustards | |
| US2461950A (en) | or x-amino quinazolines | |
| US6075033A (en) | Anthranilic acid diamides derivatives, their preparation and pharmaceutical use as anti-gastrin agents | |
| Fryer et al. | Quinazolines and 1, 4‐benzodiazepines. LXXIII. The ring expansion of 2‐chloromethylquinazoline 3‐oxides with nitromethane | |
| US4004011A (en) | 3-Pyridylamine substituted ergolines | |
| IE52051B1 (en) | Derivatives of vincaleukoblastine,their preparation and pharmaceutical formulations containing them | |
| US4115387A (en) | 3-Methyl-4-phenyl-1,2,3,4-tetrahydrobenz [H]isoquinoline hydrobromide | |
| TANAKA et al. | Cyclization of [(4-or 5-substituted-2-benzimidazolyl) thio] acetic acids. Isolation and identification of two possible isomers of substituted thiazolo [3, 2-a] benzimidazol-3 (2H)-one | |
| US4676932A (en) | Synthesis of 1-haloestradiols | |
| Nguyen et al. | Synthesis of 24-(Piperidin-1-yl, Morpholin-4-yl and 4-Methylpiperazin-1-yl)-5β-cholan-3α-ols and Four Hydroxylated 23-(4, 5-Dihydroimidazol-2-yl)-24-nor-5β-cholanes | |
| FI66185C (fi) | Nytt foerfarande foer bromering av foereningar | |
| KIKUGAWA | Chemistry of Amine-Boranes. XI. A Convenient Synthesis of Dimethylamine-Borane | |
| KR790000984B1 (ko) | 8α-에르골린 유도체의 제조방법 |